Joint (NASDAQ:JYNT – Get Free Report) announced its quarterly earnings results on Wednesday. The company reported ($0.01) EPS for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.02), MarketWatch Earnings reports. Joint had a net margin of 3.41% and a return on equity of 11.38%. The firm had revenue of $29.31 million during the quarter, compared to the consensus estimate of $29.85 million. Joint updated its FY 2023 guidance to EPS.
Joint Trading Down 1.4 %
NASDAQ JYNT traded down $0.13 on Thursday, reaching $9.22. The company had a trading volume of 171,072 shares, compared to its average volume of 134,859. The firm has a market cap of $135.34 million, a price-to-earnings ratio of 37.79 and a beta of 1.44. Joint has a fifty-two week low of $8.76 and a fifty-two week high of $20.00. The business has a 50 day moving average of $11.63 and a two-hundred day moving average of $13.85. The company has a debt-to-equity ratio of 0.06, a current ratio of 0.94 and a quick ratio of 0.94.
Insider Activity at Joint
In other Joint news, major shareholder Bandera Partners Llc purchased 584,496 shares of the firm’s stock in a transaction on Friday, August 11th. The stock was purchased at an average cost of $9.55 per share, for a total transaction of $5,581,936.80. Following the acquisition, the insider now owns 3,466,560 shares in the company, valued at approximately $33,105,648. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. Insiders purchased 846,952 shares of company stock worth $8,682,663 over the last three months. Company insiders own 4.00% of the company’s stock.
Institutional Trading of Joint
Analyst Ratings Changes
A number of research analysts have recently commented on JYNT shares. Roth Mkm dropped their price target on Joint from $16.00 to $13.00 and set a “buy” rating for the company in a research note on Thursday. StockNews.com assumed coverage on Joint in a report on Thursday, August 17th. They issued a “hold” rating for the company. Finally, Maxim Group downgraded Joint from a “buy” rating to a “hold” rating in a report on Friday, August 11th.
The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States.
- Five stocks we like better than Joint
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- WeWork Stock Soars: Meme Stock Madness or Mirage?
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Shutterstock is the Value Stock they don’t want you to know about
- How to Calculate Inflation Rate
- 3 Low-Cost ETFs That Are Crushing SPY
Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.